5-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. Its short duration –from 20 minutes to one hour– is giving ...

Algernon Pharmaceuticals’ AGNPF wholly-owned Algernon NeuroScience (AGN Neuro) successfully completed dosing the third and final cohort of its Phase 1 clinical study assessing an intravenous (IV) ...

Clinical trials on the hallucinogenic drug DMT for the treatment of depression are expected to start in January. DMT, a strong, short-acting hallucinogenic compound, remains illegal in the UK as in ...

The psychedelic drug DMT may be an effective treatment for depression, according to the results of a recently published study. The research also found that the intensity of a person’s psychedelic ...

Entering the field of psychedelic therapy, whether as a therapist or a client, means learning about an ever-growing, sometimes bewildering array of psychedelic substances. My friends in the field have ...

Cosmo Feilding-Mellen is the co-founder and CEO at Beckley Psytech, a UK-based biotech company developing psychedelic compounds. Based on a growing body of clinical research, psychedelic-assisted ...

Hallucinations. Vivid images. Intense sounds. Greater self-awareness. Those are the hallmark effects associated with the world’s four most popular psychedelic drugs. Ayahuasca, DMT, MDMA and ...

What connects a nocturnal bonfire ritual in the Peruvian rainforest with Wall Street? The potent psychedelic compound N, N-dimethyltryptamine, better known as DMT. Starting Wednesday, Mind Medicine ...